Remicade, which is a drug for rheumatoid arthritis. From Wordnik.com. [CNN Transcript Oct 22, 2009] Reference
Remicade, which is approved for inflammatory diseases, delivered year-over-year growth of. From Wordnik.com. Reference
After my first infusion of a second drug, called Remicade, I immediately felt a difference. From Wordnik.com. [News for Culpeper Star-Exponent] Reference
More surprising were uninspired showings for blockbusters such as Remicade and Risperdal. From Wordnik.com. [J&J Drug Sales Hurt Net but Forecast Is Raised] Reference
Infliximab is known by the brand name Remicade®. From Wordnik.com. [EurekAlert! - Breaking News] Reference
But the detail around Remicade makes the math a little murkier. From Wordnik.com. [Merck Trials an M&A Remedy] Reference
But losing out on Remicade could still leave investors feeling bruised. From Wordnik.com. [Merck Trials an M&A Remedy] Reference
Remicade is given as a two-hour intravenous infusion at a doctor's office. From Wordnik.com. [J&J Psoriasis Drug Shows Promise in Study] Reference
J would seek damages based on the revenue generated by Remicade and Simponi since J. From Wordnik.com. [J] Reference
These anti-TNF therapies go by names that consumers recognize as Remicade and Enbrel. From Wordnik.com. [The Autoimmune Epidemic] Reference
I do have some info in that area, since I have a kid with Crohn's who's taking Remicade. From Wordnik.com. [The Health FAQ] Reference
I've been watching my temp since then, because this can be a side effect of the Remicade. From Wordnik.com. [Sometimes you feel as if you are swimming upstream] Reference
The analyst attributed the year-over-year gain to sales in Nasonex, PEG-Intron and Remicade. From Wordnik.com. [Schering-Plough Seen Challenged By Generics in 2006] Reference
The issue centers on the anti-inflammatory drug Remicade, which J&J and Schering-Plough co-market. From Wordnik.com. [Deal Complicates Rights to Big Drug] Reference
Analysts view ustekinumab as a potential follow-up to J&J's existing anti-inflammatory drug, Remicade. From Wordnik.com. [J&J Psoriasis Drug Shows Promise in Study] Reference
Sales rose 5.5% in the latest quarter, while in the year-earlier third quarter Remicade sales were up 21%. From Wordnik.com. [J&J Drug Sales Hurt Net but Forecast Is Raised] Reference
Another laggard in the third quarter, the anti-inflammatory medicine Remicade, rebounded as the year ended. From Wordnik.com. [J&J's Net Climbs, but Patent Woes Loom] Reference
Schering-Plough holds most of the marketing rights to Remicade outside the U.S. while J&J retains those in the U.S. From Wordnik.com. [J&J Would End Schering Drug Rights] Reference
Remicade, for inflammatory disorders, also increased more slowly than in the past, as it faces increased competition. From Wordnik.com. [J&J Drug Sales Hurt Net but Forecast Is Raised] Reference
Two years ago had 95% clearing on Remicade then had a severe allergic reaction and my body could no longer tolerate the infusion. From Wordnik.com. [Psoriasis Guru » Blog Archive » New Psoriasis Drug from Johnson and Johnson: Stelara (Ustekinumab)] Reference
J&J sells Remicade, an anti-inflammatory drug, with Schering-Plough, and a deal for the company could give it full rights to the drug. From Wordnik.com. [Drug-Industry Shakeout Hits Small Firms Hard] Reference
LearnThatWord and the Open Dictionary of English are programs by LearnThat Foundation, a 501(c)3 nonprofit.
Questions? Feedback? We want to hear from you!
Email us
or click here for instant support.
Copyright © 2005 and after - LearnThat Foundation. Patents pending.